Dr. Reddy’s Laboratories Ltd. is open to buying more over-the-counter drug brands in Russia, as well as acquiring a Russian drug manufacturer in response to pharmaceutical policy changes. Chief Financial Officer Umang Vohra said the company is trying to raise the share of non-prescription over-the-counter drugs in its Russian portfolio to 40%-45% from less than a third. This will reduce the proportion of prescription products, which now account for about 72% of sales, making the Indian generic drug maker less susceptible to any move by the Russian government to introduce drug price controls.
